Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
83 participants
INTERVENTIONAL
2019-10-09
2020-04-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Methodological Study of the Effect of a Lotion Containing Nature Based Microbial Extract on Atopic Skin
NCT06499766
Efficacy and Safety of an Ectoine-containing Cream in the Treatment of Mild to Moderate Atopic Dermatitis
NCT01079897
Skin Efficacy and Tolerability of a Cosmetic Product Combination Over 3 Months in Subjects With Atopic Eczema
NCT05790083
The Effect of Nature-based Exposure on the Immune System and Skin Health of Atopic Dermatitis Patients.
NCT06129136
Effect of Pollen Challenges on Dermal Symptoms in Patients With Atopic Dermatitis
NCT01475994
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Berry Oil Cream
Study part 1: Administered to a chosen eczema lesion on randomized body half 1-2 times/d or more frequently (use reported to study logbook) for two weeks. Also administered to forearm (randomized body half) twice/d for two weeks. Study part 2: Administered to randomized body half 1-2 times/d for five weeks.
Berry Oil Cream
Cream containing berry and plant oils and humectants; a medical device product in development
Control
Study part 1: A chosen eczema lesion on randomized body half is an untreated control for two weeks. Also one forearm (on randomized body half) is a control with no treatment for two weeks.
No interventions assigned to this group
Reference cream
A commercial reference cream, not containing berry and plant oils. Study part 2: Administered to randomized body half 1-2 times/d for five weeks.
Reference Cream
Commercial refence cream not containing berry and plant oils.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Berry Oil Cream
Cream containing berry and plant oils and humectants; a medical device product in development
Reference Cream
Commercial refence cream not containing berry and plant oils.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Known hypersensitivity to ingredients of the study creams
* Medication seriously affecting immune function
12 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cliniscan Ltd
UNKNOWN
Petra Larmo
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Petra Larmo
Ph.D., R&D Manager
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Risto Oksman, MD
Role: PRINCIPAL_INVESTIGATOR
Cliniscan Ltd
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mehiläinen (Private Clinic)
Turku, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BOAE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.